Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 12:22 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1513–1536 of 13,937 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Type 2 Diabetes Mellitus
Interventions: Dapagliflozin, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 35 Years to 70 Years
Enrollment: 116 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 3
States / cities: San Diego, California • Baton Rouge, Louisiana • Philadelphia, Pennsylvania

Conditions: Pain, Colorectal Adenomas, Colorectal Cancer
Interventions: Air Insufflation method., CO2 insufflation, Water Immersion/CO2, Water Exchange/CO2, Water Immersion/AI, Water Exchange/AI; Other
Lead sponsor: Presidio Ospedaliero Santa Barbara; Other
Eligibility: 18 Years to 85 Years
Enrollment: 624 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Urinary Tract Infections
Interventions: D-Mannose; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 20 Years and older · Female only
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Colorectal Carcinoma
Interventions: Best Practice, Health Promotion and Education, Survey Administration; Other
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 138 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Diabetes During Pregnancy
Interventions: High-Protein Beverage (Genius Gourmet Sparkling Protein Water), Standard Clear Liquid Diet, Continuous Glucose Monitoring (Abbott Freestyle Libre); Dietary Supplement · Other · Device
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis, Cardiomyopathies, Heart Diseases
Interventions: acoramidis, Placebo Oral Tablet; Drug
Lead sponsor: Eidos Therapeutics, a BridgeBio company; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 632 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 40
States / cities: Los Angeles, California • Santa Monica, California • Aurora, Colorado + 32 more

Conditions: Advance Care Planning
Interventions: I kua na'u "Let Me Carry Out Your Last Wishes"; Behavioral
Lead sponsor: Tufts Medical Center; Other
Eligibility: 55 Years and older
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Obesity, Type 2 Diabetes, Dental Caries
Interventions: Sugar-Sweetened Beverage (SSB) Video, Water Video, Control; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 12 Years to 12 Years
Enrollment: 326 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Polypharmacy
Interventions: Bundled hyperpolypharmacy; Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 76 Years and older
Enrollment: 2,471 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Oakland, California

Conditions: Lung Diseases, Interstitial
Interventions: Nintedanib, Placebo; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 9
States / cities: Los Angeles, California • Aurora, Colorado • Indianapolis, Indiana + 6 more

Conditions: Chronic Cough (CC), Refractory Chronic Cough, Unexplained Chronic Cough
Interventions: BCS+inactive, BCS+active; Behavioral · Combination Product
Lead sponsor: University of Montana; Other
Eligibility: 18 Years to 99 Years
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 3
States / cities: Aurora, Colorado • Atlanta, Georgia • Missoula, Montana

Conditions: Allergy
Interventions: Short Ragweed Pollen Allergenic Extract, Placebo; Biological
Lead sponsor: Greer Laboratories; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 429 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Warrenton, Virginia

Conditions: Parkinson Disease
Interventions: Donepezil; Drug
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Diabetic Foot Ulcer, Infection
Interventions: PluroGel N, PluroGel; Drug
Lead sponsor: PluroGen Therapeutics, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 15
States / cities: Phoenix, Arizona • Los Angeles, California • Oakland, California + 8 more

Conditions: Tardive Dyskinesia, Antipsychotic Agents
Interventions: Pyridoxine, Placebo; Dietary Supplement
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 80 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Secondary Dysmenorrhea, Dysmenorrhea, Dysmenorrhea Secondary, Polycystic Ovary Syndrome, Endometriosis, Fibroid, Menstrual Pain, Menstrual Disorder, Menstrual Discomfort
Interventions: Iyengar Yoga Therapy; Other
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 12 Years to 65 Years · Female only
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Lennox Gastaut Syndrome
Interventions: Clemizole HCl, Placebo; Drug
Lead sponsor: Epygenix; Industry
Eligibility: 2 Years to 55 Years
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 22
States / cities: Little Rock, Arkansas • Orange, California • Miami, Florida + 16 more

Conditions: Cellulitis, Abscess, Drain Abscess, Impetigo, Skin Infection, Antibiotic Duration, Behavioral Economics
Interventions: Default Duration order Panel; Behavioral
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: 3 Months to 99 Years
Enrollment: 1,634 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Alzheimer Disease, Mild Cognitive Impairment
Interventions: Pramlintide challenge test; Drug
Lead sponsor: Boston University; Other
Eligibility: 60 Years to 90 Years
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 3
States / cities: Indianapolis, Indiana • Boston, Massachusetts • Jamaica Plain, Massachusetts

Conditions: Grief, Depressive Symptoms
Interventions: DVD Intervention Arm; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 107 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2017
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Alcoholic Hepatitis
Interventions: Placebo, 10 mg Obeticholic Acid (OCA); Drug
Lead sponsor: Naga P. Chalasani; Other
Eligibility: 21 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 4
States / cities: Indianapolis, Indiana • Rochester, Minnesota • Philadelphia, Pennsylvania + 1 more

Conditions: Glioblastoma
Interventions: Enzastaurin Hydrochloride, Placebo, Temozolomide, Radiotherapy; Drug · Other · Radiation
Lead sponsor: Denovo Biopharma LLC; Industry
Eligibility: 18 Years and older
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 47
States / cities: Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 38 more

Conditions: Fetal Membranes, Premature Rupture, Labor, Induced/IS
Interventions: Transcervical Foley catheter; Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 12 Years to 55 Years · Female only
Enrollment: 169 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 3
States / cities: Birmingham, Alabama • Newark, Delaware • Greenville, South Carolina

Conditions: Ischemic Foot Ulcer
Interventions: Endovascular Revascularization; Procedure
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 110 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Search by objective public record fields.

Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes

Comparison of Methods to Distend the Colon During Insertion: CO2, Air Insufflation, Water-aided Colonoscopy

Nutraceutical Efficacy for rUTI

CoGENES Randomized Controlled Trial (RCT)

Fueling Labor: Protein Supplementation for Intrapartum Glucose Control

Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy

I Kua na'u Advance Care Planning for Native Hawaiian Elders

The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages

Bundled Hyperpolypharmacy Deprescribing

A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD)

Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough

Efficacy and Safety Study Of Short Ragweed Pollen Sublingual-Oral Immunotherapy

Donepezil to Treat Dementia in Parkinson's Disease

Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers

Randomized Controlled Trial of Pyridoxine for Tardive Dyskinesia

Iyengar Yoga Therapy for Dysmenorrhea and Endometriosis

An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care

Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease

Impact of a Neonatal-Bereavement-Support DVD on Grief

Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH)

A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1

Foley Catheter for Labor Induction in Women With Term and Near Term Membrane Rupture

Ischemic Foot Ulcers: Is Intervention Better Than Wound Care Alone